Dermorphin Analog
| RP13522 | |
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| RP13522 | |
|
|
|
|
|
|
| Ask us a question | |
The dermorphin-derived peptide [Dmt1] dermorphin analog labels m-opioid receptors with high affinity and selectivity in receptor binding assays. In mice, radiant heat tail-flick assays, [Dmt1] dermorphin analog produces profound spinal and supraspinal analgesia, being approximately 5000 and 100 times more potent respectively than morphine in causing these analgesia on a molar basis. When administered systemically, [Dmt1] dermorphin analog has been shown to be over 200 times more potent than morphine. |
| Sequence |
TYR-d-ARG-PHE-SAR-TYR-PRO-SER-NH2 |
| Molecular Formula | C44H59N11O10 |
| C Terminal | NH2 |
| Molecular Weight | 901.43 |
| Purity | > 95% |
| Solubility | Dermorphin analog is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
| Storage | Before use, store dermorphin analog in the DRY form at 0-5°C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions. |